Quarterly report · Q2
3645.TEDINET S100PYWE
Period2022-06-01 → 2022-11-30
Filed2023-01-16
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2021-06-01 → 2021-11-30 | Cons. | Net sales |
| Operating income | ¥192m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Operating income | ¥249m | 2021-06-01 → 2021-11-30 | Cons. | Operating income |
| Ordinary income | ¥220m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥454m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥247m | 2021-06-01 → 2021-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥221m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥329m | 2021-06-01 → 2021-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥131m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥385m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥247m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥144m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Net income | ¥250m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥2.6bn | at 2021-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2021-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥951m | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥869m | at 2021-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥85m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥68m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥70m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.74 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.19 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.98 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.42 | 2021-06-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.39 | 2021-09-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥66m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥389m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥390m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2021-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2021-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2021-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥483m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥483m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥326m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥76m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥76m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥8,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥32m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥19,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥77m |
| —segment total | revenue | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue external | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥28,000 |
| —segment total | segment profit | 2021-06-01 → 2021-11-30 | ¥436m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥28,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2021-11-30 | ¥437m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 492
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)Mooreみらい監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高砂 晋平 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)吉原 浩 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 1702073000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 1997979000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 3745765000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 246608000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 219749000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 454334000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 246832000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 130867000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 384857000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 247990000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 148105000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 405989000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 1579473000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 1967701000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1737533000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 2585524000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 3446468000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 3154441000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 28.42 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 14.74 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 43.98 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.6028 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.5601 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.5414 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 84897000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 59445000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 342551000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | 68499000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -32156000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -355110000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -69864000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -906000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 282234000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 950908000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1168714000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1128788000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 11.39 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 8.19 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10773000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |